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Abstract 
Isoalantolactone, a sesquiterpene lactone compound possesses antifungal, antibacteria, an-
tihelminthic and antiproliferative activities. In the present study, we found that isoalantolac-
tone inhibits growth and induces apoptosis in pancreatic cancer cells. Further mechanistic 
studies revealed that induction of apoptosis is associated with increased generation of reactive 
oxygen species, cardiolipin oxidation, reduced mitochondrial membrane potential, release of 
cytochrome c and cell cycle arrest at S phase. N-Acetyl Cysteine (NAC), a specific ROS in-
hibitor restored cell viability and completely blocked isoalantolactone-mediated apoptosis in 
PANC-1  cells  indicating  that  ROS  are  involved  in  isoalantolactone-mediated  apoptosis. 
Western blot study showed that isoalantolactone increased the expression of phosphorylated 
p38  MAPK,  Bax,  and  cleaved  caspase-3  and  decreased  the  expression  of  Bcl-2  in  a 
dose-dependent manner. No change in expression of phosphorylated p38 MAPK and Bax was 
found when cells were treated with isoalantolactone in the presence of NAC, indicating that 
activation of these proteins is directly dependent on ROS generation. The present study 
provides evidence for the first time that isoalantolactone induces ROS-dependent apoptosis 
through intrinsic pathway. Furthermore, our in vivo toxicity study demonstrated that iso-
alantolactone did not induce any acute or chronic toxicity in liver and kidneys of CD1 mice at 
dose of 100 mg/kg body weight. Therefore, isoalantolactone may be a safe chemotherapeutic 
candidate for the treatment of human pancreatic carcinoma. 
Key words: Isoalantolactone; PANC-1; ROS; Apoptosis; NAC. 
Introduction 
Pancreatic  cancer  is  the  fourth  most  common 
cause  of  cancer-related  deaths  in  United  States  [1]. 
Despite  advancements  in  diagnosis,  surgery,  radio-
therapy and chemotherapy, the overall 5 year survival 
rate remains less than 3 years while the median sur-
vival rate is about 6 months [2]. Surgical abscission 
remains the only option for long term survival of pa-
tients. However, difficulty in achieving early diagno-
sis and aggressive nature of this type of cancer limit 
the  surgical  operation  to  only  about  10%  patients. 
Therefore, the majority of pancreatic cancer patients 
are  treated  with  chemotherapy  [3].  Currently,  gem-
citabine (Gem) is the most effective chemotherapeutic 
drug for pancreatic cancer. However, even with this 
drug, the overall survival rate remains considerably 
low. Moreover, Gem is highly toxic to tumor cells as 
well as normal cells [4, 5]. Several other cytotoxic and 
chemotherapy agents such as cisplatin, fluorouracil, 
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docetaxel  and  irinotecan  have  been  tested  as  single 
agent or in combination with gemcitabine for pancre-
atic cancer, however most of these studies failed to 
ameliorate overall patient survival compared to gem-
citabine [3]. Furthermore, most of these drugs have 
been  shown  to  cause  severe  hepatotoxicity  [6].  As 
pancreatic  cancer  responds  poorly  to  the  existing 
conventional chemotherapy, therefore it is important 
to study the anti-pancreatic cancer mechanism using 
newly identified effective anticancer compounds that 
exhibit low toxicity on normal cells. 
A number of recent reports indicated that phy-
tochemicals targeting ROS metabolism can selectively 
kill the cancer cells by raising the level of ROS above a 
toxic threshold. As cancer cells contain higher level of 
endogenous ROS than normal cells, the toxic thresh-
old can be easily achieved in cancer cells compared to 
normal cells [7, 8]. In the present study, we performed 
high throughput screening of compound library from 
Chinese  herbs,  using  pancreatic  cancer  cell  line 
PANC-1, in the presence or absence of NAC, a specific 
ROS inhibitor. This screening method allowed us to 
identify anti-pancreatic cancer compounds targeting 
ROS  metabolism.  Isoalantolactone,  a  sesquiterpene 
lactone compound was identified as a potent inhibitor 
of  pancreatic  carcinoma  cells  during  screening  pro-
cess.  Sesquiterpene  lactones  are  plant-derived  com-
pounds used in the manufacture of traditional medi-
cines  for  the  treatment  of  inflammatory  diseases, 
headache and infections [9]. Over the past few years, a 
large body of pharmacological studies has provided 
convincing  evidences  of  the  anticancer  property  of 
sesquiterpene lactones against various human cancer 
cell  lines  [10,  11].  At  present,  several  sesquiterpene 
lactone compounds are in cancer clinical trials against 
breast,  colorectal,  kidney,  prostate,  acute  myeloid 
leukemia,  acute  lymphoblastic  leukemia,  and  non 
small  lung  cancer  treatment  [10].  However,  the  an-
ti-pancreatic cancer potential of sesquiterpene lactone 
compounds is not well studied.  
Isoalantolactone  is  one  of  the  major  sesquiter-
pene lactone compounds, isolated from the roots of 
Anula helenium and possesses multiple biological ac-
tivities  including  antibacteria,  antifungal,  antihel-
minthic and antiproliferative [12]. The above findings 
encouraged  us  to  study  the  anti-pancreatic  cancer 
potential of isoalantolactone as well as its toxicity on 
normal  cells  in  vitro  and  hepatotoxicity  and  ne-
phrotoxicity in vivo. 
Materials and Methods 
Reagents 
Isoalantolactone  (IALT)  was  purchased  from 
Tauto Biotech Co., Ltd. (Shanghai, China) and purity 
(> 99%) was determined by HPLC. RNase A, Propid-
ium iodide (PI), calcein acetoxymethylester (Calcein 
AM),  Hoechst  33258,  10-Nnonyl  Acridine  Orange 
(NAO),  Dimethyl  Sulfoxide  (DMSO), 
[3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
Bromide]  (MTT),  Dulbecco's  Modified  Eagle's  Me-
dium  (DMEM),  DMEM/F12  medium,  fatal  bovine 
serum (FBS), penicillin and streptomycin  were pur-
chased from Sigma (Beijing, China). Apoptosis assay 
kit, Reactive oxygen species kit, JC-1, and Antibodies 
specific to p-p38 MAPK, Bax, Bcl-2, cytochrome c, and 
caspase-3 were purchased from Beyotime institute of 
Technology (Shanghai, China). Antibodies specific to 
β-actin  and  horseradish  peroxidase-conjugated  sec-
ondary antibodies (goat-anti-rabbit, goat-anti-mouse) 
were purchased from Santa Cruz (Beijing, China). 
Cell Culture and Treatments 
The  human  pancreatic  carcinoma  PANC-1, 
BxPC3,  HPAC  cells  and  monkey  non-tumorigenic 
COS-7 cells were obtained from Shanghai Cell Bank. 
PANC-1,  BxPC3  and  COS-7  cells  were  cultured  in 
Dulbecco's Modified Eagle's Medium (DMEM) sup-
plemented  with  10%  fatal  bovine  serum  (FBS),  100 
units/mL  penicillin  and  100  µg/mL  streptomycin 
whereas  HPAC  cells  were  cultured  in  DMEM/F12 
medium supplemented with 10% (FBS), 100 units/mL 
penicillin  and  100  µg/mL  streptomycin  and  main-
tained  at  37°C  with  5%  CO2  in  humidified  atmos-
phere. Cells were treated with various concentrations 
of  isoalantolactone  dissolved  in  DMSO  with  a  final 
DMSO concentration of 1% for 24 h. DMSO treated 
cells were used as control.  
 
Determination of Cell Viability 
Cell viability was assessed by MTT assay as de-
scribed previously [13]. Briefly PANC-1, BxPC3, and 
HPAC  cells  were  treated  with  dimethyl  sulfoxide 
(DMSO)  or  isoalantolactone  in  the  presence  or  ab-
sence of 3 mM NAC for 24 h. Following treatment, the 
MTT reagent was added (500µg/mL) and cells were 
further incubated at 37°C for 4 h. Subsequently 150 μL 
DMSO was added to dissolve farmazan crystals and 
absorbance was measured at 570 nm in a microplate 
reader (Thermo Scientific). The percentage of cell via-
bility was calculated as follows: 
Cell viability (%) = (A570sample – A570blank) / 
(A570control – A570blank)×100 
The IC50 Values were calculated using GraphPad 
Prism 5. Int. J. Biol. Sci. 2012, 8 
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Live/Dead assay 
Live  and  dead  cells  were  quantified  using  the 
fluorescent probes calcein acetoxymethylester (calcein 
AM) and propidium iodide (PI). Celcein AM is cell 
membrane  permeable  and  stains  only  viable  cells 
whereas PI is cell membrane impermeable and stains 
only dead cells. To determine the effect of isoalanto-
lactone  on  cancer  cells  and  normal  cells,  pancreatic 
carcinoma cells (PANC-1) and normal cells (COS-7) 
were treated with 20 and 40 µM isoalantolactone in 
the  presence  or  absence  of  NAC  for  24  h.  Subse-
quently,  treated  and  untreated  cells  were  collected, 
washed  with  phosphate  buffered  saline  (PBS)  and 
incubated with PBS solution containing 2 µM calcein 
AM and 4 µM PI in the dark for 20 min at room tem-
perature.  After  washing,  cells  were  resuspended  in 
PBS and analyzed for the fluorescence of calcein and 
PI by flow cytometry (Beckman Coulter, Epics XL). 
Apoptosis assay by Annexin V-FITC and pro-
pidium iodide (PI) staining 
PANC-1 cells were treated with isoalantolactone 
in a dose- and time-dependent manner in the presence 
or absence of 3 mM NAC. After treatment, cells were 
harvested, washed with PBS, and resuspended in 200 
µL of binding buffer containing 5 µL Annexin V and 
put  in  the  dark  for  10  min  according  to  the  kit  in-
structions (Beyotime, Shanghai, China). After incuba-
tion,  cells  were  labeled  with  10  µL  PI  and  samples 
were  immediately  analyzed  by  flow  cytometry 
(Beckman Coulter, Epics XL). 
Hoechst 33258 staining for Nuclei Condensa-
tion and Fragmentation 
PANC-1 cells were treated with 40 µM isoalan-
tolactone for various time points (0, 4, 12, and 24 h). 
The cells were fixed with 4% paraformaldehyde for 30 
min at room temperature. After washing with  PBS, 
cells were stained with Hoechst 33258 (50 µg/mL) at 
37°C for 20 min in the dark. At the end, the cells were 
washed and resuspended in PBS for the observation 
of  nuclear  morphology  under  fluorescence  micro-
scope (Olympus 1x71).  
Cell cycle analysis 
PANC-1 cells were treated with 20 and 40 µM 
isoalantolactone for 24 h. After treatment, cells were 
harvested, washed with PBS and fixed with 70% eth-
anol at 4°C for overnight. After washing twice with 
PBS, cells were stained with a solution containing 50 
μg/mL PI and 100 μg/mL RNase A for 30 min in the 
dark at room temperature. The DNA contents for cell 
cycle  phase  distribution  were  analyzed  by  flow  cy-
tometry (Beckman Coulter, Epics XL) using Cell Quest 
software. 
Measurement of Reactive Oxygen Species 
(ROS) 
The  intracellular  changes  in  ROS  generation 
were  measured  by  staining  the  cells  with  
2',  7'  -dichlorofluorescein-diacetate  (DCFH-DA)  as 
described  previously  [13].  The  fluorescent  dye 
DCFH-DA is a cell membrane permeable and is con-
verted into cell membrane impermeable nonfluores-
cent compound DCFH by intracellular esterases. Ox-
idation of DCFH by reactive oxygen species produces 
a highly fluorescent DCF. The fluorescence intensity 
of DCF inside the cells is proportional to the amount 
of  peroxide  produced.  Briefly  PANC-1  cells  were 
treated with 20 and 40 µM isolantolactone for 24 h. 
After treatment, cells were further incubated with 10 
μM DCFH-DA at 37°C for 30 min. Subsequently, cells 
were harvested, rinsed, re-suspended in PBS, filtered 
with  300  apertures  and  analyzed  for  
2', 7' -dichlorofluorescein (DCF) fluorescence by flow 
cytometry.  
Measurement of Mitochondrial Membrane 
Lipid Peroxidation 
Mitochondrial membrane lipid peroxidation was 
determined by measuring the oxidation of intracellu-
lar  cardiolipin  by  staining  the  cells  with  
10-N-nonyl acridine orange (NAO), a probe specific 
for mitochondrial membrane cardiolipin [14]. Briefly 
PANC-1  cells  were  treated  with  20  and  40  µM  iso-
alantolactone for 24 h. After washing with PBS, cells 
were further incubated with 5 µM NAO in the dark at 
room temperature for 30 min. After washing, samples 
were analyzed by flow cytometry. 
Measurement of Mitochondrial Membrane 
Potential (MMP) 
MMP  was  determined  using  JC-1  probe  (Be-
yotime)  as  described  previously  [15,  16].  JC-1  is 
widely  used  to  monitor  mitochondrial  membrane 
depolarization. In healthy cells with high mitochon-
drial membrane potential, JC-1 spontaneously forms 
complexes  known  as  J-aggregates  with  intense  red 
fluorescence. Whereas, in apoptotic or unhealthy cells 
with  low  mitochondrial  membrane  potential,  JC-1 
remains in the  monomeric form, which shows  only 
green  fluorescence.  Thus  mitochondrial  depolariza-
tion is indicated by a decrease in red/green fluores-
cence  intensity  ratio.  Briefly  after  treating  the  cells 
with 20 and 40 µM isoalantolactone for 24 h, cells were 
stained with 10 µM of JC-1 for 25 min at 37°C. After Int. J. Biol. Sci. 2012, 8 
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washing,  cells  were  analyzed  for  the  decrease  in 
red/green fluorescence by flow cytometry. 
Immunobloting 
Proteins  were  isolated  from  control  and  iso-
alantolactone-treated  cells  as  described  previously 
[13].  40  µg  proteins  were  electrophoresed  on  10% 
SDS-PAGE and transferred to PVDF membrane. After 
blocking  with  5%  (w/v)  non-fat  milk  and  washing 
with  Tris-buffered  saline-Tween  solution  (TBST), 
membranes  were  incubated  overnight  at  4°C  with 
p-p38 MAPK (1:1000), Bcl-2 (1:1000), Bax (1:300), cy-
tochrome  c  (1:200),  caspase-3  (1:500)  and  β-actin 
(1:400)  antibodies  respectively.  After  washing,  the 
blots  were  incubated  with  horseradish  peroxi-
dase-conjugated  goat  anti-rabbit  IgG  or  goat  an-
ti-mouse IgG secondary antibodies (1:5000) for 1 h at 
room temperature. After washing with TBST, signals 
were detected using ECL plus chemiluminescence kit 
on X-ray film (Millipore Corporation). All the bands 
obtained were quantified by densitometry using Im-
age J software. 
In Vivo Studies 
In  vivo  studies  for  acute  and  chronic  toxicity 
were conducted on 10-12 week old CD1 mice weigh-
ing 27-30 g. The mice were maintained in a specific 
pathogen-free  grade  animal  facility  on  a  12-h 
light/dark cycles at 25±2°C. Mouse procedures were 
approved by the Experimental Animal Committee of 
Jilin  University.  Mice  were  randomly  divided  into 
four groups. Group A (n = 4) administered with 50 µL 
DMSO intraperitonially for 7 days; Group B (n = 4) 
administered with isoalantolactone (100 mg/kg body 
weight) in 50 µL DMSO intraperitonially for 7 days; 
Group C (n = 4) administered with 50 µL DMSO for 30 
days and Group D (n = 4) administered with isoalan-
tolactone (100 mg/kg body weight) in 50 µL DMSO 
intraperitonially for 30 days. 
At the first and last day of the experiments, the 
body weight of each mouse was measured. At the end 
of experiments (at dose day 7 for acute toxicity & dose 
day 30 for chronic toxicity), mice were anesthetized 
using Pentobarbital sodium (50 mg/kg ip), blood was 
collected via cardiac puncture, allowed to clot for 10 
min  and  centrifuge  at  1000×g  for  10  min  at  room 
temperature.  Serum  was  separated  and  stored  at 
-20°C until analysis. The liver and kidneys were ex-
cised and processed for hematoxylin and eosin stain-
ing followed established procedures. 
Serum Biomarker Analysis 
The  acute  and  chronic  toxicity  of  isoalantolac-
tone on liver and kidneys was determined by meas-
uring the serum levels of aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), total bilirubin 
(TBIL), blood urea nitrogen (BUN) and creatinine (Cr) 
using blood auto analyzer (Hitechi 7170). 
Statistical Analysis 
  The results are expressed as Mean ± SEM and 
statistically  compared  with  control  group  or  within 
the  groups  using  one  way  ANOVA  followed  by 
Tukey’s  Multiple  Comparison  Test.  Student’s  T-test 
was  used  to  determine  significance  when  only  two 
groups  were  compared  and  p<0.05  was  considered 
statistically significant. 
Results 
Isoalantolactone Inhibibited Pancreatic Can-
cer Cells Growth in Vitro. 
The cytotoxic effect of isoalantolactone on pan-
creatic  carcinoma  was  evaluated  using  PANC-1, 
BxPC3 and HPAC cell lines. Treatment with isoalan-
tolactone for 24 h inhibited PANC-1 cell growth in a 
dose-dependent manner (Fig 1A). The inhibition rate 
was  above  90%  at  80  µM  and  the  concentration  to 
achieve 50% growth inhibition (IC50) was 40 µM. A 
similar trend in loss of cell viability was observed in 
BxPC3 and HPAC cells on isoalantolactone treatment 
with IC50 values 43 and 48 µM respectively (Fig. 1B & 
C).  Pretreatment  with  3  mM  NAC,  a  specific  ROS 
scavenger,  restored  the  viability  of  cells  indicating 
that  isoalantolactone  exerts  cytotoxic  effect  on  cell 
viability  through  ROS  generation.  PANC-1  cell  line 
was found more sensitive to isoalantolactone and se-
lected for further mechanistic study. 
Cancer Cells are more sensitive to Isoalanto-
lactone than Normal cells 
The  cytotoxic  effect  of  isoalantolactone  on 
PANC-1  cells  was  further  confirmed  by  live/dead 
assay. Apart from cancer cells, the cytotoxic effect of 
isoalantolactone  on  normal  cells  (COS-7  cells)  was 
also evaluated. For this purpose, pancreatic carcinoma 
cells (PANC-1) and normal cells (COS-7) were treated 
with 20 and 40 µM isoalantolactone for 24 h and live 
and  dead  cells  were  quantified  using  fluorescent 
probes calcein AM/PI and flow cytometry. The data 
showed that treatment of cells with isoalantolactone 
reduced the viability of PANC-1 and COS-7 cells in a 
dose-dependent  manner.  However,  the  viability  of 
COS-7  cells  was  significantly  higher  than  PANC-1 
cells after exposure to 20 and 40 µM isoalantolactone 
for 24 h (Fig 2). Next, to examine whether ROS scav-
enger, NAC protects the cells from cytotoxic effect of 
isoalantolactone,  PANC-1  and  COS-7  cells  were  in-Int. J. Biol. Sci. 2012, 8 
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cubated with 40 µM isoalantolactone in the presence 
of 3 mM NAC for 24 h and cell viability was deter-
mined  by  live/dead  assay.  The  data  demonstrated 
that  NAC  completely  abolished  isoalantolac-
tone-induced cytotoxic effect in PANC-1 as well as in 
COS-7  cells.  The  data  indicate  that  isoalantolac-
tone-induced  cytotoxicity  in  PANC-1  as  well  as  in 
COS-7 cells is associated with generation of intracel-
lular ROS. The differential toxicity of isoalantolactone 
between normal cells and cancer cells may be due to 
much lower level of endogenous ROS in normal cells 
than cancer cells. 
Isoalantolactone induces Apoptosis and S 
phase Arrest in PANC-1 Cells 
Apoptosis  and  cell  cycle  arrest  are  two  major 
causes of cell growth inhibition. The effect of isoalan-
tolactone on cell apoptosis was analyzed by Annexin 
V-FITC/PI  staining  using  flow  cytometry  and 
Hoechst  33258  staining  using  fluorescence  micro-
scope.  The  results  showed  that  isoalantolactone  in-
duced  apoptosis  in  PANC-1  cells  in  a  dose-  and 
time-dependent  manner.  Treatment  of  cells  with  20 
and  40  µM  isoalantolactone  significantly  increased 
apoptosis rate (62.67±2.82 and 69±4.23 vs 2.88±0.59 in 
control,  P<0.01)  (Fig.  3A).  Pretreatment  with  NAC 
completely blocked the apoptotic effect of isoalanto-
lactone  indicating  that  induction  of  apoptosis  is 
ROS-dependent. Next, we treated the cells with 40 µM 
isoalantolactone and level of ROS and apoptosis rates 
were  observed  at  different  time  points.  The  data 
demonstrated that isoalantolactone induced apoptosis 
(Fig.  3B)  and  ROS  generation  (Data  not  shown)  in 
PANC-1 cells in a time-dependent manner. The iso-
alantolactone-induced  apoptosis  was  also  identified 
using  Hoechst  33258  staining  and  fluorescence  mi-
croscope at different time points. In the control group, 
the  nuclei  were  round  and  stained  homogeneously 
whereas  isoalantolactone-treated  cells  showed  con-
densed  and  marked  fragmented  nuclei  in  a 
time-dependent manner (Fig. 4). Taken together, the 
data  demonstrate  that  isoalantolactone  induces 
apoptosis  in  PANC-1  cells  in  a  dose-  and 
time-dependent manner which is correlated with ROS 
generation. 
 
 
Figure 1.  Effect of isoalantolactone on PANC-1, BxPC3 and HAPC cells viability. Cells were treated with different concentrations of 
isoalantolactone in the presence or absence of NAC for 24 h and cell viability was measured by MTT assay. (A) PANC-1 cells were treated 
with various concentrations of isoalantolactone for 24 h. (B) BxPC3 cells were treated with various concentrations of isoalantolactone for 
24 h. (C) HPAC cells were treated with various concentrations of isoalantolactone for 24 h. Data are expressed as Mean ± SEM (n=3). 
Columns not sharing the same superscript letter differ significantly (P<0.05). Int. J. Biol. Sci. 2012, 8 
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Figure 2. Determination of cell viability by Calcein/PI staining and Flow Cytometry (A) PANC-1 cells were treated with 20 and 40 µM 
isoalantolactone in the presence or absence of NAC for 24 h. (A1) Control, (A2) 20 µM, (A3) 40 µM, (A4) 40 µM isoalantolactone + 3 mM 
NAC. (B) COS-7 cells were treated with 20 and 40 µM isoalantolactone in the presence or absence of NAC for 24 h. (B1) Control, (B2) 
20 µM, (B3) 40 µM, (B4) 40 µM isoalantolactone + 3 mM NAC. (C) Data are expressed as Mean ± SEM (n=3). Columns not sharing the 
same superscript letter differ significantly (P<0.05). 
 
Induction of cell cycle arrest was analyzed using 
PI staining and flow cytometry. Our results showed 
that isoalantolactone arrested the cell cycle at S phase 
in  a  dose-dependent  manner.  Treatment  with  iso-
alantolactone at 20 and 40 µM showed a significant 
increase  in  S  phase  from  19.73±1.94  to  31±1.53  & 
49.23±1.43 with a corresponding decrease in G0/G1 
phase from 59.48±3.43 to 56.13±1.82 & 47.36±0.91 and 
G2/M phase from 22.5±1.21 to 13.16±0.78 & 3.26±0.69 
respectively at P<0.05 (Fig. 5).  
Isoalantolactone induces Increased Genera-
tion of ROS in PANC-1 Cells 
Intracellular  ROS  generation  in  PANC-1  cells 
was evaluated by flow cytometry using DCFH-DA. 
As shown in Fig. 6A, the level of ROS in PANC-1 cells, 
treated with 20 and 40 µM isoalantolactone was sig-
nificantly higher (21.33±1.45 & 33.0±1.73 vs 1.02±0.47 
in control group, P<0.05). 
Isoalantolactone causes Cardiolipin Oxidation 
(CL oxidation) and Disrupt Mitochondrial 
Membrane Potential (MMP) in PANC-1 Cells 
 Reactive  oxygen  species  once  generated  cause 
massive  oxidation  of  redox  sensitive  proteins  and 
lipids  leading  to  mitochondrial  damage.  Next  we 
asked  if  isoalantolactone  can  cause  mitochondrial 
cardiolipin (CL) oxidation. Cardiolipin is exclusively 
found in mitochondria and cytochrome c is bound to 
cardiolipin. Oxidation of cardiolipin results in libera-
tion of cytochrome c from mitochondrial membrane. 
To  examine  CL  oxidation,  cells  were  stained  with 
NAO, and CL oxidation was determined by flow cy-
tometry.  The  data  showed  that  isoalantolactone 
caused  CL  oxidation  in  PANC-1  cells  in  a 
dose-dependent manner (Fig. 6B). Int. J. Biol. Sci. 2012, 8 
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Figure 3. Flow cytometry analysis of apoptosis in PANC-1 cells treated with isoalantolactone in a dose- and time-dependent manner in 
the presence or absence of 3 mM NAC. (A) PANC-1 cells were treated with 20 and 40 µM isoalantolactone in the presence or absence 
of NAC for 24 h. (A1) Control, (A2) 20 µM, (A3) 40 µM, (A4) 40 µM isoalantolactone + 3 mM NAC, (A5) Data are expressed as Mean 
± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05). (B) PANC-1 cells were treated with 40 µM 
isoalantolactone for various time intervals. (B1) Control, (B2, B3 and B4) PANC-1 cells were treated with 40 µM isoalantolactone for 4, 
8 and 12 h respectively. (B5) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly 
(P<0.05). 
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Figure 4. Induction of apoptosis by isoalantolactone in 
PANC-1 cells using Hoechst 33258 staining and fluo-
rescence microscope. PANC-1 cells were treated with 
40 µM isoalantolactone for various time intervals and 
nuclear  morphological  changes  were  observed  using 
Hoechst 33258 staining and fluorescence microscope. 
The cells treated with 40 µM isoalantolactone for var-
ious time intervals exhibited apoptotic changes such as 
condensed  chromatin  and  fragmented  nuclei  as  indi-
cated by arrows. (A) Control, (B, C, and D) Cells were 
treated with 40 µM isoalantolactone for 4, 12 and 24 h 
respectively. Cell were fixed with 4% paraformaldehyde, 
washed with  PBS,  resuspended in  PBS  and  observed 
under  fluorescence  microscope  for  nuclear  morpho-
logical changes. Scale bar = 20 µm. 
 
 
 
 
 
 
 
 
 
Figure 5. Flow cytometry analysis of cell cycle phase distribution in PANC-1 cells treated with 20 and 40 µM isoalantolactone for 24 h. 
(A) Control, (B) 20 µM, (C) 40 µM. (D) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ 
significantly (P<0.05) Int. J. Biol. Sci. 2012, 8 
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Figure 6. Flow cytometry analysis of ROS generation (A) and Cardiolipin oxidation (B) in PANC-1 cells treated with 20 and 40 µM IALT 
in the presence or absence of 3 mM NAC for 24 h. (A1) Control, (A2) 20 µM, (A3) 40 µM, (A4) 40 µM isoalantolactone + 3 mM NAC, 
(A5) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05). (B1) Control, 
(B2) 20 µM, (B3) 40 µM, (B4) 40 µM isoalantolactone + 3 mM NAC, (B5) Data are expressed as Mean ± SEM (n=3). Columns not sharing 
the same superscript letter differ significantly (P<0.05) 
 
 
Depolarization in MMP is a characteristic feature 
of apoptosis. Excessive intracellular ROS production 
has  been  shown  to  induce  apoptosis  by  disrupting 
MMP [16, 17]. To investigate the role of ROS in iso-
alantolactone-mediated  apoptosis,  we  determined 
MMP in PANC-1 cells using JC-1 and flow cytometry. 
As shown in Fig. 7, MMP in cells treated with 20 and 
40  µM  isoalantolactone  was  significantly  lower 
(89.43±1.75% & 84.40±0.92% vs 98.03±0.55% in control 
group, P<0.05). To further confirm the involvement of 
ROS  in  CL  oxidation  and  disruption  of  MMP,  cells 
were  treated  with  3  mM  NAC.  Pretreatment  with Int. J. Biol. Sci. 2012, 8 
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NAC completely prevented CL oxidation and drop in 
MMP,  indicating  that  both  these  processes  are 
ROS-dependent. 
Effect of Isoalantolactone on Major Mito-
chondrial Apoptosis Regulatory Proteins 
 To further characterize mitochondrial apoptosis 
in detail, the effect of isoalantolactone on the expres-
sion of some major proteins (p38 MAPK, Bax, Bcl-2, 
cytochrome c and caspase-3) involved in mitochon-
drial apoptosis pathway was determined by Western 
blot  analysis.  Previous  studies  have  shown  that  in-
creased intracellular ROS generation can activate p38 
MAP kinase [18] and activated p38 MAPK plays im-
portant  role  in  activation  and  translocation  of  Bax 
which  ultimately  results  in  release  of  cytochrome  c 
and  activation  of  caspase-3  [19,  20].  To  observe 
whether  p38  MAP  kinase  is  activated  by  isoalanto-
lactone, we checked the expression of p38 MAPK us-
ing a phosphospecific antibody recognizing active p38 
MAPK by Western blot analysis. The results showed 
an  increased  expression  of  phosphorylated  p38 
MAPK in isoalantolactone-treated cells (Fig. 8A).  
 
 
Figure 7. Flow cytometry analysis of mitochondrial membrane potential in PANC-1 cells treated with 20 and 40 µM isoalantolactone in 
the presence or absence of 3 mM NAC for 24 h. (A) Control, (B) 20 µM, (C) 40 µM, (D) 40 µM IALT + 3 mM NAC, (E) Data are expressed 
as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05). Int. J. Biol. Sci. 2012, 8 
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Figure 8. Effect of isoalantolactone on the expression of major apoptosis regulatory proteins (A) PANC-1 cells were treated with 20 and 
40 µM isoalantolactone for 24. The expressions of p-p38, Bcl-2, Bax, cytochrome c and caspase-3 were determined by Western blotting 
and quantified by Image J software. (B) PANC-1 cells were treated with 20 and 40 µM isoalantolactone in the presence of 3 mM NAC for 
24 h. The expressions of p-p38 and Bax were determined by Western blot analysis and quantified by Image J software. (C) Data are 
expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter within the group differ significantly (P<0.05) 
 
To further investigate, we analyzed the expres-
sion  of  Bax,  Bcl-2,  cytochrome  c  and  caspase-3  in 
PANC-1  cells  after  exposure  to  20  and  40  µM  iso-
alantolactone for 24 h. As shown in Fig. 8A, isoalan-
tolactone  treatment  increased  the  expression  of  Bax 
and decreased the expression of Bcl-2 accompanied by 
the release of cytochrome c from mitochondria to cy-
tosol  and  caspase-3  activation  in  a  dose-dependent 
manner. To investigate whether increased ROS gen-
eration  is  functionally  linked  to  isoalantolac-
tone-induced p38 MAPK and Bax activation, we ob-
served the expressions in the cell lysates treated with 
isoalantolactone in the presence of NAC. No change 
in the expression levels of p38 MAPK and Bax was 
observed, further confirming that activation of both 
these proteins is ROS-dependent (Fig. 8B).  
Isoalantolactone Exerts no Toxic Effect on 
Liver and Kidneys in Vivo 
The acute and chronic toxic effects of isoalanto-
lactone in CD1 mice were assessed by measuring the 
changes in body weight, blood biochemistry and his-
topathology of liver and kidneys in comparison with 
control groups.  
The  drug  was  well  tolerated  by  mice  and  no 
mortality or any sign of pharmacotoxicity were found 
at a dose of 100 mg/kg during both experimental pe-
riods  (7  &  30  days).  Body  weight  gains  and  food 
consumption were comparable for control and treated 
mice  during  both  experimental  periods  and  there 
were  no  drug-related  changes  in  histopathological 
and blood biochemistry parameters. The histopatho-
logical  changes  in  liver  and  kidneys  were  assessed 
using hematoxylin and eosin staining and correlated 
with liver and renal function biomarkers. No obvious 
morphological  changes  were  observed  in  liver  and 
kidney  structures  of  control  and  treatment  groups 
(Fig  9).  These  results  were  further  confirmed  by 
measuring the changes in liver function biomarkers 
(AST, ALT and TBIL) and renal function biomarkers Int. J. Biol. Sci. 2012, 8 
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(BUN and Cr) in the serum of control and treatment 
groups. As shown in Table 1, there was a slight in-
crease  in  serum  ALT  and  AST  level  of  treatment 
group at dose day 7 but this increase was not signifi-
cantly different (P<0.05) from control group. Howev-
er,  a  significant  increase  in  TBIL  concentration  was 
found  in  treatment  group  (1.43±0.26  vs 0.76±0.12  in 
control, P<0.05) at dose day 7. Similarly the changes in 
renal function biomarkers (Cr & BUN) were not sig-
nificantly  different  (P<0.05)  in  the  serum  of  control 
and treatment groups at dose day 7. The concentra-
tion of Cr slightly increased whereas concentration of 
BUN slightly decreased in treatment group (Table  1). 
Interestingly, the serum level of AST, ALT, TBIL and 
BUN slightly decreased when mice were injected with 
isoalantolactone at a dose of 100 mg/kg for 30 days 
(Table  1).  However,  these  alterations  do  not  differ 
significantly from control group (P<0.05).  
 
 
 
 
 
 
Figure 9. Hematoxylin & Eosin stained sections of Kidney and Liver from CD1 mice administered with vehicle or isoalantolactone at a 
dose of 100 mg/kg body weight. The liver and kidneys from control and IALT-treated mice were excised and processed for hematoxylin 
and eosin staining followed established procedures. (A) Kidney section; Scale bar = 100 µm. (B) kidneys sections representing structure of 
glomeruli; Scale bar = 20 µm. (C) Liver section; Scale bar = 20 µm. 
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Table 1: Biochemical effect of isoalantolactone on Liver and Kidneys function Biomarkers in CD1 mice. 
Groups  Body Weight (g)   ALT 
 (U/L) 
 AST 
 (U/L) 
 TBIL 
 (µmol/L) 
 Cr 
 (µmol/L) 
 BUN 
(mmol/L) 
Before 
treatment 
After 
treatment 
Group A  28.8±1.5  30.4±1.3  53.33±6.64  156±5.50   0.76±0.12  19.46±2.79  7.95±1.10 
Group B  28.1±1.7  26.9±1.8  59.00±11.01  158.7±10.17  1.43±0.26*  28.03±7.53  7.39±0.66 
Group C  29.5±2.1  33.8±2.2  46.5±8.68  143.25±5.94  0.97±0.20  20.27±2.68  9.78±1.20 
Group D  30.0±1.9  33.7±1.6  41.0±6.41  137.50±12.2  0.72±0.14  20.62±5.34  9.12±0.66 
Data are expressed as Mean ± SEM, n = 4 
* Significantly different from control, p<0.05 
Group A & B were daily given 50 µL DMSO and isoalantolactone (100 mg/kg) for 7 days respectively. 
Group C & D were daily given 50 µL DMSO and isoalantolactone (100 mg/kg) for 30 days respectively. 
 
 
Discussion 
Previous studies have indicated that root extract 
of Inula helenium has inhibitory activity against vari-
ous cancer cell lines [21, 22]. One recent study by Pal 
et al. has shown that Inula recemosa extract containing 
alantolactone and isoalantolactone induces apoptosis 
and  increased  ROS  generation  in  HL-60  cells  [12]. 
However, the role of ROS remained undefined. In the 
present study, we addressed the question of whether 
or  not  isoalantolactone  could  induce  apoptosis  and 
increase ROS generation in PANC-1 cells. To address 
the  question,  we  examined  the  antiproliferative, 
apoptotic and ROS generating ability of isoalantolac-
tone using MTT assay and flow cytometry. The results 
showed  that  isoalantolactone  inhibited  growth  of 
PANC-1 cells and induced apoptosis and ROS gener-
ation in a dose-dependent manner. To probe the pos-
sible  role  of  ROS,  we  performed  MTT  assay, 
Live/dead assay and apoptosis assay in the presence 
of a specific ROS inhibitor, NAC. The results showed 
that  pretreatment  with  NAC  restored  cell  viability 
and  blocked  the  apoptotic  effect  of  isoalantolactone 
completely.  The  data  demonstrate  clearly  that  iso-
alantolactone  exerts  its  growth  inhibitory  effect 
through ROS generation. The present study provides 
evidence  for  the  first  time  that  isoalantolactone  in-
duces ROS-dependent apoptosis in PANC-1 cells. 
Over  production  of  ROS  results  in  oxidative 
damage including; lipid peroxidation, protein oxida-
tion and DNA damage. In addition, ROS are known to 
act  as  second  messengers  to  activate  diverse  re-
dox-sensitive  signalling  cascades  including  mito-
chondrial intrinsic apoptotic cascade through interac-
tion with Bcl-2 family proteins, MAPK family member 
p38  and  its  downstream  transcription  factors  [17, 
23-25]. Bcl-2 family proteins include a wide variety of 
anti-apoptotic  proteins  such  as  Bcl-2  and 
pro-apoptotic  proteins  such  as  Bax,  which  are  key 
players  of  mitochondrial  outer  membrane  permea-
bilization and apoptosis regulation [26, 27]. ROS have 
been shown to inhibit anti-apoptotic protein Bcl-2 and 
activate and translocate pro-apoptotic protein Bax to 
outer  mitochondrial  membrane  (OMM)  where  it 
forms oligomers, which are thought to be important in 
the formation of permeability transition pores (PTP) 
and  cytochrome  c  release.  Some  other  studies  have 
shown  that  ROS  activate  p38  MAPK  [18]  and  acti-
vated p38 MAPK promotes the activation and trans-
location of Bax to OMM [25, 28]. 
In the present study, isoalantolactone increased 
ROS  production  in  PANC-1  cells  in  a  time-  and 
dose-dependent manner. To investigate whether iso-
alantolactone can trigger intrinsic apoptotic cascade in 
PANC-1 cells, we examined the expression of Bcl-2, 
p38 MAPK and Bax proteins in the cells of each group 
using Western blot analysis. The results demonstrated 
that  expression  of  Bcl-2  gradually  decreased  while 
expression of p38 MAPK and Bax increased in cells of 
treatment groups in a dose-dependent manner, sug-
gesting  that  isoalantolactone  induces  apoptosis 
through  intrinsic  pathway.  In  addition,  massive  CL 
oxidation,  reduction  in  MMP  and  cytochrome  c  re-
lease  into  cytosol  in  isoalantolactone-treated  cells 
further support the above findings. These results are 
consistent with previous study where n-hexane frac-
tion of roots of Inula recemosa reduced the MMP with 
increase expression of Bax and cytochrome c release in 
HL-6o cells [12]. 
Once cytochrome c is released to cytosol, it binds 
and activates caspase-9, which then results in the ac-
tivation of other downstream caspases and ultimately 
caspase-3.  Caspase-3  has  been  identified  as  a  main 
executioner  of  apoptotic  response  inside  the  cells. 
Finally activated caspase-3 cleaved effector proteins 
including PARP, and induced DNA fragmentation in 
nucleus which eventually leads to cell death [17]. In 
the present study, an increase in the cleaved caspase-3 Int. J. Biol. Sci. 2012, 8 
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has  been  observed  in  isoalantolactone-treated  cells. 
These  results  demonstrate  clearly  that  isoalantolac-
tone induces apoptosis in PANC-1 cells through mi-
tochondrial  dysfunction  and  caspase-3  activation.  It 
has been reported previously that increased intracel-
lular ROS generation induces the cell cycle arrest at S 
phase [29, 30]. Our cell cycle analysis results clearly 
confirm these findings.  
 A number of previous studies have shown that 
the  phytochemicals  targeting  ROS  metabolism  can 
selectively kill the cancer cells by raising the level of 
ROS above a toxic threshold [7, 8, 31]. As cancer cells 
contain higher level  of basal endogenous ROS than 
normal cells [32], the toxic threshold value in cancer 
cells can be achieved faster compared to normal cells 
[33].  In  the  present  study,  isoalantolactone  showed 
strong growth inhibitory effect towards PANC-1 cells; 
however this growth inhibitory effect of isoalantolac-
tone towards normal cells (COS-7) was significantly 
lower compared to the cancer cells. In addition, iso-
alantolactone did not cause any dectectable acute or 
chronic toxicity in liver and kidneys of CD1 mice in 
vivo at a dose of 100 mg/kg body weight. This selec-
tive toxicity of isoalantolactone between cancer cells 
and normal cells may be due to much lower level of 
endogenous  ROS  in  normal  cells  than  cancer  cells. 
However,  a  detailed  investigation  of  this  selective 
cytotoxicity of isoalantolactone still needs to be per-
formed in vivo. 
 In  conclusion,  our  data  demonstrated  for  the 
first  time  that  isoalantolactone  induced 
ROS-dependent  apoptosis  in  PANC-1  cells  through 
mitochondrial  intrinsic  pathway.  Furthermore,  the 
different  effect  of  isoalantolactone  between  cancer 
cells and normal cells might be dependent on differ-
ent level of endogenous ROS. Our results suggest that 
isoalantolactone may be a promising chemotherapeu-
tic drug candidate for the treatment of pancreatic car-
cinoma.  Further  investigation  is  needed  to  validate 
the contribution of isoalantolactone to tumor therapy 
in vivo. 
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